LAFAYETTE, La., April 20, 2021 (Newswire.com) – Today ThinkGenetic, Inc. (thinkgenetic.com) announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund. “After years of working… CONTINUE
From Friend to Intern to Advocate: A Reflection on My Experience with Duchenne Muscular Dystrophy
Editor’s Note: Today I am excited to release this article, written by an incredible young woman I’ve grown to know and respect as our Digital Marketing Intern. Courtney Burt’s time… CONTINUE
ThinkGenetic Declared a PULSE@MassChallenge Top Digital Health Startup
In a recent press release, PULSE@MassChallenge announced that ThinkGenetic was accepted into the Boston-based 2018 startup class out of 500 worldwide applicants. Previous startups that have participated in PULSE@MassChallenge have… CONTINUE
ThinkGenetic to Engage with Rare Disease Community at Global Genes’ 6th Annual RARE Patient Advocacy Summit
ThinkGenetic, Inc. is delighted to be participating in the 6th Annual RARE Patient Advocacy Summit and Partnering and Investor Forum to further its mission of empowering the rare disease community… CONTINUE